Asset view · 15 June 2026

US equities: what research is saying

AI summary of published research · 15 June 2026

Published research is leaning strongly bullish on US equities right now, with two catalysts doing most of the work: an expected US-Iran ceasefire lifting risk sentiment, and the AI and SpaceX IPO cycle pulling capital into tech.

Across recent third-party notes, analysts argue the peace deal is driving S&P 500 and Nasdaq futures higher, with semiconductors and travel names like United Airlines and Carnival singled out as immediate beneficiaries. A separate strategic camp keeps an overweight on US stocks, citing record corporate profit share of GDP, Washington's national security focus on AI, and locked-in AI capex through 2026. Year-end S&P targets in the published research now cluster around 7,900–8,400.

Preferred sector tilts include consumer discretionary, transports, regional banks, healthcare as defensive growth, and REITs. Some recently-published views flag a tactical pullback as likely underway, and one camp warns of downside if the Fed sounds hawkish this week — a near-term caveat, not a break in the structural bull case.

On single names, researchers are constructive on Micron, Sandisk, Intel, CVS and MGM, while a contrarian thread cautions that SpaceX's ~110x sales valuation and a six-month lockup expiry could bite later, even as near-term IPO flows stay strong. Meta is flagged tactically bearish on a failed retest of support.